Literature DB >> 24805159

Veterinary vaccines against toxoplasmosis.

Elżbieta Hiszczyńska-Sawicka1, Justyna M Gatkowska2, Marcin M Grzybowski2, Henryka Długońska2.   

Abstract

Toxoplasma gondii is a cosmopolitan protozoan parasite that infects a wide range of mammal and bird species. Common infection leads to high economic (e.g., abortions in sheep) and human (e.g., congenital toxoplasmosis or neurotoxoplasmosis in humans) losses. With one exception (Toxovax for sheep), there are no vaccines to prevent human or animal toxoplasmosis. The paper presents the current state and challenges in the development of a vaccine against toxoplasmosis, designed for farm animals either bred for consumption or commonly kept on farms and involved in parasite transmission. So far, the trials have mostly revolved around conventional vaccines and, compared with the research using laboratory animals (mainly mice), they have not been very numerous. However, the results obtained are promising and could be a good starting point for developing an effective vaccine to prevent toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24805159     DOI: 10.1017/S0031182014000481

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  20 in total

1.  Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route.

Authors:  Imran Rashid; Nathalie Moiré; Bruno Héraut; Isabelle Dimier-Poisson; Marie-Noëlle Mévélec
Journal:  Med Microbiol Immunol       Date:  2016-10-18       Impact factor: 3.402

2.  Continual renewal and replication of persistent Leishmania major parasites in concomitantly immune hosts.

Authors:  Michael A Mandell; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

3.  Induction of specific humoral immune response in mice immunized with ROP18 nanospheres from Toxoplasma gondii.

Authors:  Habibun Nabi; Imran Rashid; Nisar Ahmad; Aneela Durrani; Haroon Akbar; Saher Islam; Amna Arshad Bajwa; Wasim Shehzad; Kamran Ashraf; Nyla Imran
Journal:  Parasitol Res       Date:  2016-10-27       Impact factor: 2.289

4.  Immunity in the spleen and blood of mice immunized with irradiated Toxoplasma gondii tachyzoites.

Authors:  Nahiara Esteves Zorgi; Andrés Jimenez Galisteo; Maria Notomi Sato; Nanci do Nascimento; Heitor Franco de Andrade
Journal:  Med Microbiol Immunol       Date:  2016-01-05       Impact factor: 3.402

5.  Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins.

Authors:  Marcin M Grzybowski; Bożena Dziadek; Justyna M Gatkowska; Katarzyna Dzitko; Henryka Długońska
Journal:  Parasitol Res       Date:  2015-09-04       Impact factor: 2.289

6.  Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c mice.

Authors:  Hai-Long Wang; Li-Min Wen; Yan-Jiang Pei; Fen Wang; Li-Tian Yin; Ji-Zhong Bai; Rui Guo; Chun-Fang Wang; Guo-Rong Yin
Journal:  Parasite       Date:  2016-03-16       Impact factor: 3.000

7.  Resistance to Chronic Toxoplasma gondii Infection Induced by a DNA Vaccine Expressing GRA16.

Authors:  Ling-Ying Hu; Nian-Zhang Zhang; Fu-Kai Zhang; Meng Wang; Qi Gao; Jin-Lei Wang; Xing-Quan Zhu
Journal:  Biomed Res Int       Date:  2017-08-10       Impact factor: 3.411

8.  Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice.

Authors:  Yuan Liu; Aiping Cao; Yawen Li; Xun Li; Hua Cong; Shenyi He; Huaiyu Zhou
Journal:  BMC Infect Dis       Date:  2017-06-07       Impact factor: 3.090

9.  Immunization with Toxoplasma gondii GRA17 Deletion Mutant Induces Partial Protection and Survival in Challenged Mice.

Authors:  Jin-Lei Wang; Hany M Elsheikha; Wei-Ning Zhu; Kai Chen; Ting-Ting Li; Dong-Mei Yue; Xiao-Xuan Zhang; Si-Yang Huang; Xing-Quan Zhu
Journal:  Front Immunol       Date:  2017-06-29       Impact factor: 7.561

Review 10.  Calcium-dependent protein kinases are potential targets for Toxoplasma gondii vaccine.

Authors:  Masoud Foroutan; Fatemeh Ghaffarifar
Journal:  Clin Exp Vaccine Res       Date:  2018-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.